{{Rsnum
|rsid=5085
|Gene=APOA2
|Chromosome=1
|position=161222721
|Orientation=minus
|GMAF=0.1896
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=APOA2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 2.7 | 29.2 | 68.1
| HCB | 8.0 | 40.1 | 51.8
| JPT | 6.2 | 39.8 | 54.0
| YRI | 0.0 | 11.6 | 88.4
| ASW | 0.0 | 22.8 | 77.2
| CHB | 8.0 | 40.1 | 51.8
| CHD | 10.2 | 37.0 | 52.8
| GIH | 0.0 | 22.8 | 77.2
| LWK | 0.0 | 17.3 | 82.7
| MEX | 10.3 | 43.1 | 46.6
| MKK | 1.9 | 18.6 | 79.5
| TSI | 5.9 | 32.4 | 61.8
| HapMapRevision=28
}}

A meta-analysis of several [[APOA2]] SNPs (including this one) found no association between any APOA2 SNPs studied and type-2 diabetes.{{PMID|19216768|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}